The primary end point of postpericardiotomy syndrome occurred in 35 patients ( 19.4 % ) assigned to colchicine and in 53 ( 29.4 % ) assigned to placebo ( absolute difference , 10.0 % ; 95 % CI , 1.1 % -18.7 % ; number needed to treat = 10 ) .